attributable
to non-communicable
diseases (NCDs) has been observed since the country’s economic transition
KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, N.SH.,
ZAGIDULLIN, SH.Z.,
KZHYSHKOWSKA, J.G (2019) Background and objective: Chronic obstructive pulmonary
disease (COPD) is a complex chronic
Korytina, G.F.,
Aznabaeva, Y.G.,
Kochetova, O.V.,
Nasibullin, T.R.,
Akhmadishina, L.Z.,
Khusnutdinova, N.N.,
Zagidullin, N. Sh.,
Victorova, T.V. (2023) Chronic obstructive pulmonary
disease (COPD) is a complex lung
disease characterized by progressive
FARKHUTDINOV, I.,
ZLOBINA, A.,
FARKHUTDINOV, A.,
FARKHUTDINOVA, L.,
MATVEENKO, I.,
VOLFSON, I. (2020) was identified in the development of only two
diseases-hypoferric anemia and endemic goiter. The development
AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) ,S-palladaheterocycle, inhibition of cytochromes P450 has been
modeled by molecular docking of four palladaheterocycle stereoisomers
for onset of type 2 diabetes mellitus in patients aged 25 years. Type 2 diabetes mellitus is a
diseaseASSOCIATIONS OF THE NRF2/KEAP1 PATHWAY AND ANTIOXIDANT DEFENSE GENE POLYMORPHISMS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEKorytina, G.F.,
Akhmadishina, L.Z.,
Aznabaeva, Y.G.,
Kochetova, O.V.,
Zagidullin, N.S.,
Kzhyshkowska, J.G.,
Zagidullin, S.Z.,
Viktorova, T.V. (2019) Background and objective: Chronic obstructive pulmonary
disease (COPD) is a complex chronic
Background objectives: Chronic obstructive pulmonary
disease (COPD) is a complex chronic
diseases. In fact, several studies have documented the induction of corneal endothelial-like cells (CECs